GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
$3.78
-0.0200 (-0.526%)
At Close: Apr 19, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $3.60 $5.28 Friday, 19th Apr 2024 AVXL stock ended at $3.78. This is 0.526% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 5.56% from a day low at $3.60 to a day high of $3.80.
90 days $3.60 $6.90
52 weeks $3.60 $10.31

Historical Anavex Life Sciences Corp. prices

Date Open High Low Close Volume
2021-09-17 $17.07 $17.80 $16.80 $17.63 1 638 728
2021-09-16 $17.09 $17.27 $16.66 $16.97 742 134
2021-09-15 $16.84 $17.36 $16.71 $17.07 1 053 034
2021-09-14 $18.15 $18.31 $16.77 $16.82 1 330 476
2021-09-13 $18.75 $18.76 $18.05 $18.13 730 852
2021-09-10 $19.00 $19.32 $18.67 $18.70 576 552
2021-09-09 $18.60 $19.62 $18.46 $18.91 762 161
2021-09-08 $19.11 $19.15 $18.30 $18.63 683 631
2021-09-07 $19.47 $20.29 $19.02 $19.14 821 225
2021-09-03 $19.87 $20.07 $19.11 $19.48 743 714
2021-09-02 $20.25 $20.65 $19.66 $19.97 682 589
2021-09-01 $19.31 $20.34 $18.96 $20.22 1 000 207
2021-08-31 $18.65 $20.19 $18.56 $19.49 1 798 917
2021-08-30 $18.83 $19.19 $18.31 $18.54 726 915
2021-08-27 $18.50 $19.32 $18.11 $19.03 943 416
2021-08-26 $19.34 $19.78 $18.53 $18.55 764 927
2021-08-25 $18.78 $19.79 $18.65 $19.04 885 853
2021-08-24 $20.15 $20.27 $18.96 $19.40 1 206 747
2021-08-23 $18.68 $19.77 $18.53 $19.72 899 140
2021-08-20 $18.22 $18.77 $18.03 $18.36 839 066
2021-08-19 $18.51 $18.96 $18.25 $18.29 792 775
2021-08-18 $19.18 $19.59 $18.64 $18.81 679 597
2021-08-17 $18.88 $19.48 $18.53 $19.33 786 083
2021-08-16 $19.31 $19.46 $18.42 $19.00 989 701
2021-08-13 $19.12 $20.97 $18.59 $19.55 1 800 251
Click to get the best stock tips daily for free!

About Anavex Life Sciences Corp.

Anavex Life Sciences . Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Golden Star

Ticker Date Change Price
DOOR Apr 17 0.0305% $131.35
LNG Apr 17 3.29% $156.81
FCN Apr 16 1.75% $207.62
ELV Apr 16 4.82% $506.97
FTSL Apr 16 0.217% $46.08
AKR Apr 05 3.15% $16.53
ITCI Apr 05 5.74% $68.44
SARK Mar 28 18.79% $26.88
SON Mar 26 0.83% $56.64
ARCC Mar 25 2.34% $20.12
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT